AI assistant
Sending…
Merck & Co., Inc. — Director's Dealing 2021
Mar 2, 2021
284_dirs_2021-03-02_50bf1b10-ecdb-4003-82b4-9425397534bb.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Merck & Co., Inc. (MRK)
CIK: 0000310158
Period of Report: 2021-02-26
Reporting Person: FRAZIER KENNETH C (Director, Chairman, President & CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-02-26 | Common Stock | A | 175249 | $72.62 | Acquired | 586795.063 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock - 401(k) Plan | 4240.5202 | Indirect |
Footnotes
F1: Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 3/29/18. Performance shares were paid out at 166 percent of target awards. Includes dividends accrued over the three-year performance period ending December 31, 2020.
F2: Holdings include shares acquired in dividend reinvestment transactions.
F3: Includes shares acquired and dividends earned through January 8, 2021 in the Merck U.S. Savings Plan, a 401(k) plan.
More from Merck & Co., Inc.
Regulatory Filings
2026
May 22
Prospectus
2026
May 20
Regulatory Filings
2026
May 18
Prospectus
2026
May 18
Regulatory Filings
2026
May 13
Interim / Quarterly Report
2026
May 4
Major Shareholding Notification
2026
Apr 30
Regulatory Filings
2026
Apr 30
Annual Report
2026
Apr 8
Proxy Solicitation & Information Statement
2026
Apr 8